Drug Manufacturers - Specialty & Generic Industry Overview
The Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, includes 106 publicly traded companies with a combined market capitalization of $347.30B. The industry is led by Takeda Pharmaceutical Company Limited (TAK), Haleon plc (HLN), Teva Pharmaceutical Industries Limited (TEVA).
Among the 106 listed Drug Manufacturers - Specialty & Generic companies, market capitalizations range from $50.14B (Takeda Pharmaceutical Company Limited) down to $24.55B (United Therapeutics Corporation), highlighting the wide size disparity across the industry. The average market cap across the industry is $3.28B, reflecting a mix of established large-cap players and smaller growth-oriented companies.
Drug Manufacturers - Specialty & Generic Industry Valuation
The Drug Manufacturers - Specialty & Generic industry currently trades at an average price-to-earnings (P/E) ratio of 47.5. This elevated multiple indicates that investors are pricing in strong future earnings growth across Drug Manufacturers - Specialty & Generic companies.
Drug Manufacturers - Specialty & Generic Dividend Profile
8 out of 106 Drug Manufacturers - Specialty & Generic companies (8%) currently pay dividends to shareholders. The average dividend yield across dividend-paying Drug Manufacturers - Specialty & Generic stocks is 3.42%. Most Drug Manufacturers - Specialty & Generic companies reinvest earnings into growth rather than paying dividends, which is typical for earlier-stage or high-growth industries.
Largest Drug Manufacturers - Specialty & Generic Companies by Market Cap
| Company | Ticker | Market Cap | P/E Ratio |
|---|---|---|---|
| Takeda Pharmaceutical Company Limited | TAK | $50.14B | 41.8 |
| Haleon plc | HLN | $40.92B | 18.5 |
| Teva Pharmaceutical Industries Limited | TEVA | $40.30B | 25.8 |
| Zoetis Inc. | ZTS | $33.63B | 13.2 |
| United Therapeutics Corporation | UTHR | $24.55B | 21.4 |
The table above shows the top 5 Drug Manufacturers - Specialty & Generic companies ranked by market capitalization. P/E ratios reflect trailing twelve months earnings where available.
Frequently Asked Questions
What is the largest Drug Manufacturers - Specialty & Generic company? The largest Drug Manufacturers - Specialty & Generic company by market capitalization is Takeda Pharmaceutical Company Limited (TAK), valued at $50.14B. Use the full listing below to explore all Drug Manufacturers - Specialty & Generic companies and compare their financials.
How many Drug Manufacturers - Specialty & Generic stocks are there? There are 106 publicly traded Drug Manufacturers - Specialty & Generic companies listed on major US exchanges, ranging from Takeda Pharmaceutical Company Limited (TAK) to United Therapeutics Corporation (UTHR) by market capitalization. This directory spans 3 pages, with all companies sorted by market cap for easy comparison.
How many Drug Manufacturers - Specialty & Generic stocks pay dividends? 8 of the 106 Drug Manufacturers - Specialty & Generic companies (8%) currently distribute dividends. The average yield among payers is 3.42%. Dividend policies vary significantly across Drug Manufacturers - Specialty & Generic companies — browse individual stock pages for the latest yield and payout details.
What is the average P/E ratio for Drug Manufacturers - Specialty & Generic stocks? The average trailing P/E ratio for the Drug Manufacturers - Specialty & Generic industry is 47.5x. Individual company valuations can vary widely — click through to any stock page for detailed valuation metrics.
Explore Drug Manufacturers - Specialty & Generic Stocks on StockVS
StockVS provides detailed fundamental data, historical price charts, and side-by-side comparisons for all 106 Drug Manufacturers - Specialty & Generic companies. Browse individual stock pages for in-depth analysis, or use our comparison tool to evaluate two Drug Manufacturers - Specialty & Generic stocks head to head. All data is updated regularly to reflect the latest available financials.